RAPH
Raphael Pharmaceutical Inc.
Set alert
1.51 USD 0.00 0.00%
1.51 Day range 1.51
0.748 52-week range 1.51
- YTD
- +7.86%
- 1 year
- +51.00%
- Open
- 1.51
- Prev close
- 1.51
- Mkt cap
- 30.47M
- Vol
- 100
- Avg vol
- 1
- EPS
- -0.05
- P/E
- 0.00
More statistics
- Low
- 1.51
- High
- 1.51
Financial health
Altman Z-Score
-2874.67 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -21.4×
FY 2021 5y median -12.4× FY 2025
P/S 0.0×
FY 2021 5y median 0.0× FY 2025
P/B -19.1×
FY 2021 5y median 156× FY 2025
P/FCF -130×
FY 2021 5y median -24.0× FY 2025
EV/EBITDA -22.0×
FY 2021 5y median -12.4× FY 2025
EV/Sales 0.0×
FY 2021 5y median 0.0× FY 2025
FCF Yield -0.8%
FY 2021 5y median -4.2% FY 2025
Profitability
Gross Margin 0.0%
FY 2021 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2021 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2021 5y median 0.0% FY 2025
ROE 89.3%
FY 2021 5y median -1256.1% FY 2025
ROIC 89.0%
FY 2021 5y median -1244.9% FY 2025
ROA -2413.2%
FY 2021 5y median -1008.4% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2021 FY 2025
Operating Income 17.5%
FY 2021 FY 2025
EPS (diluted) 19.6%
FY 2021 FY 2025
Free Cash Flow 60.5%
FY 2021 FY 2025
Financial Health
Current Ratio 0.0×
FY 2021 5y median 1.4× FY 2025
Quick Ratio 0.0×
FY 2021 5y median 1.4× FY 2025
Debt / Equity -0.0×
FY 2021 5y median 0.0× FY 2025
Net Debt / EBITDA 0.0×
FY 2021 5y median 0.1× FY 2025
Interest Coverage -69.2×
FY 2021 5y median -444× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31